methyl salicylate has been researched along with Cytokine Release Syndrome in 1 studies
methyl salicylate: used in over-the-counter liniments, ointments, lotions for relief of musculoskeletal aches and pains; has hemolytic effect on human & sheep erythrocytes; RN given refers to parent cpd; structure in Merck Index, 9th ed, #5990
methyl salicylate : A benzoate ester that is the methyl ester of salicylic acid.
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, X | 1 |
Gong, N | 1 |
Tian, F | 1 |
Zhang, S | 1 |
Zhang, Y | 1 |
Wang, Y | 2 |
Qing, G | 1 |
Li, F | 1 |
Xu, Y | 1 |
Zhang, L | 1 |
Wang, J | 1 |
Ni, Q | 1 |
Gan, Y | 1 |
Gu, C | 1 |
Jiang, H | 1 |
Huang, X | 1 |
Shi, X | 1 |
Zhang, T | 1 |
Wu, Y | 1 |
Liang, XJ | 1 |
1 other study available for methyl salicylate and Cytokine Release Syndrome
Article | Year |
---|---|
Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel.
Topics: Animals; Antibodies, Neutralizing; Cell- and Tissue-Based Therapy; Cytokine Release Syndrome; Cytoki | 2023 |